Login / Signup
Safety Margin for Plasma Hyperviscosity in Cardiovascular Disease Patients after COVID-19 Vaccination for Thrombosis Prevention.
Rujittika PhD Mungmunpuntipantip
Viroj Wiwanitkit
Published in:
Arquivos brasileiros de cardiologia (2022)
Keyphrases
</>
cardiovascular disease
end stage renal disease
coronavirus disease
sars cov
newly diagnosed
ejection fraction
chronic kidney disease
type diabetes
prognostic factors
pulmonary embolism
coronary artery disease
metabolic syndrome
cardiovascular events